MedPath

陕西大生制药科技有限公司

Ownership
-
Established
2001-02-26
Employees
-
Market Cap
-
Website
www.dashengpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Nitroglycerin Patch

Product Name
硝酸甘油贴片
Approval Number
国药准字H61022578
Approval Date
Sep 22, 2021
NMPA

Pediatric Compound Sulfamethoxazole Granules

Product Name
小儿复方磺胺甲噁唑颗粒
Approval Number
国药准字H61023265
Approval Date
Sep 22, 2021
NMPA

Glycerol

Product Name
甘油
Approval Number
国药准字H61021088
Approval Date
Sep 22, 2021
NMPA

Glycerol Enema

Product Name
开塞露
Approval Number
国药准字H61020930
Approval Date
Sep 22, 2021
NMPA

Nitroglycerin Solution

Product Name
硝酸甘油溶液
Approval Number
国药准字H61021093
Approval Date
Aug 10, 2021
NMPA

Foscarnet Sodium

Product Name
膦甲酸钠
Approval Number
国药准字H20064602
Approval Date
Mar 2, 2021
NMPA

Sodium Gluconate

Product Name
葡萄糖酸钠
Approval Number
国药准字H20060979
Approval Date
Mar 2, 2021
NMPA

Chlorhexidine Gluconate Solution

Product Name
葡萄糖酸氯己定溶液
Approval Number
国药准字H20064352
Approval Date
Mar 2, 2021
NMPA

Povidone Iodine

Product Name
聚维酮碘
Approval Number
国药准字H61021091
Approval Date
Aug 3, 2020
NMPA

Chlorhexidine Acetate

Product Name
醋酸氯己定
Approval Number
国药准字H20045044
Approval Date
Aug 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.